|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Transplantation of primary and reversibly immortalized human liver cells and other gene therapies in acute liver failure and decompensated chronic liver disease显示文摘Studies performed in experimental small animalswith hepatic-based metabolic disorders but nostructural liver disease,including Gunn andanalbuminaemic rats and rabbits with inherited low-density lipoprotein receptor deficiency,have shownthat up to 95% of hepatocytes transplanted into thespleen or liver remain in these sites,withimprovement in metabolic function | Stephen M.Riordan Roger Williams | 2000 | World Journal of Gastroenterology2000，6，5： | 13 |
| 2 | Employee involvement climate and organizational effectiveness显示文摘 | Christine M.Riordan Robert J.Vandenberg Hettie A.Richardson | 2005 | Hum. Resour. Manage2005，，： | 1 |
| 3 | Review article: portal vein thrombosis – new insights into aetiology and management显示文摘 | G. J. M.Webster A. K.Burroughs S. M.Riordan | 2004 | Alimentary Pharmacology & Therapeutics2004，，1： | 1 |
| 4 | Review article: portal vein thrombosis – new insights into aetiology and management显示文摘 | G. J. M.Webster A. K.Burroughs S. M.Riordan | 2004 | Alimentary Pharmacology & Therapeutics2004，，1： | 1 |
| 5 | Cannabinoids and endocannabinoids as therapeutics for nervous system disorders:preclinical models and clinical studies显示文摘Cannabinoids are lipophilic substances derived from Cannabis sativa that can exert a variety of effects in the human body.They have been studied in cellular and animal models as well as in human clinical trials for their therapeutic benefits in several human diseases.Some of these include central nervous system(CNS)diseases and dysfunctions such as forms of epilepsy,multiple sclerosis,Parkinson’s disease,pain and neuropsychiatric disorders.In addition,the endogenously produced cannabinoid lipids,endocannabinoids,are critical for normal CNS function,and if controlled or modified,may represent an additional therapeutic avenue for CNS diseases.This review discusses in vitro cellular,ex vivo tissue and in vivo animal model studies on cannabinoids and their utility as therapeutics in multiple CNS pathologies.In addition,the review provides an overview on the use of cannabinoids in human clinical trials for a variety of CNS diseases.Cannabinoids and endocannabinoids hold promise for use as disease modifiers and therapeutic agents for the prevention or treatment of neurodegenerative diseases and neurological disorders. | R.Scott Duncan Sean M.Riordan Matthew C.Gernon Peter Koulen | 2024 | Neural Regeneration Research2024，19，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员